Literature DB >> 19775516

Estimation of donor usability for islet transplantation in the United States with the kyoto islet isolation method.

Shinichi Matsumoto1, Hirofumi Noguchi, Nobuyo Hatanaka, Masayuki Shimoda, Naoya Kobayashi, Andrew Jackson, Nicholas Onaca, Bashoo Naziruddin, Marlon F Levy.   

Abstract

The quality of donor pancreata is important for successful islet isolation. However, in some countries like Japan, the number of donor pancreata is very low; therefore, marginal donors have been used with less restrictive donor criteria. In order to use marginal donor pancreata, we established the Kyoto islet isolation method (KIIM). According to United Network for Organ Sharing (UNOS) in 2005, more than 6,000 pancreata were not clinically used in the US. In this study, we applied the KIIM for brain-dead donors and reevaluated donor usability based on the Japanese islet donor criteria. Islets were isolated with the Ricordi method using pancreata stored in University of Wisconsin (UW) solution (UW group) or by the two-layer method (TLM group) or the TLM combined with ductal injection (DI group). We implemented the KIIM (KIIM group) to confirm the effect of the KIIM on brain-dead donors. Donor charts in Texas from 2005 to 2006 were reviewed. If pancreata were not used clinically, the reason was reviewed and donors were reevaluated based on Japanese criteria. There were no significant differences of islet yield, viability, and purity between the UW and TLM groups. The DI group significantly improved islet yields and isolations were further improved in the KIIM group [UW: 251,663 +/- 60,217 islet equivalent (IE); TLM: 243,738 +/- 54,170 IE; DI: 498,639 +/- 28,853 IE; KIIM: 678,286 +/- 55,853]. The KIIM provided high-quality islets in high numbers from islet isolations from brain-dead donors. A total of 236 donor charts were reviewed and 194 pancreata (82%) were not used. Of these, 185 cases identified the reasons that the pancreata were not used. When we applied the Japanese criteria, an additional 82 cases out of 185 (44%) seem to be suitable for islet isolations. With the KIIM, more than 2,500 additional donor pancreata can be used for islet isolation in the US every year when the Japanese criteria are applied.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19775516     DOI: 10.1177/096368970901805-610

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  7 in total

1.  Improvement of collagenase distribution with the ductal preservation for human islet isolation.

Authors:  Masayuki Shimoda; Takeshi Itoh; Koji Sugimoto; Shuichi Iwahashi; Morihito Takita; Daisuke Chujo; Jeffery A Sorelle; Bashoo Naziruddin; Marlon F Levy; Paul A Grayburn; Shinichi Matsumoto
Journal:  Islets       Date:  2012-03-01       Impact factor: 2.694

2.  Variables associated with islet yield in autologous islet cell transplantation for chronic pancreatitis.

Authors:  Morihito Takita; Bashoo Naziruddin; Shinichi Matsumoto; Hirofumi Noguchi; Masayuki Shimoda; Daisuke Chujo; Takeshi Itoh; Koji Sugimoto; Nicholas Onaca; Jeffrey P Lamont; Luis F Lara; Marlon F Levy
Journal:  Proc (Bayl Univ Med Cent)       Date:  2010-04

3.  Transplantation of insulin-producing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic rats.

Authors:  Pei-Jiun Tsai; Hwai-Shi Wang; Yi-Ming Shyr; Zen-Chung Weng; Ling-Chen Tai; Jia-Fwu Shyu; Tien-Hua Chen
Journal:  J Biomed Sci       Date:  2012-04-30       Impact factor: 8.410

4.  Comparisons of Differentiation Potential in Human Mesenchymal Stem Cells from Wharton's Jelly, Bone Marrow, and Pancreatic Tissues.

Authors:  Shih-Yi Kao; Jia-Fwu Shyu; Hwai-Shi Wang; Chi-Hung Lin; Cheng-Hsi Su; Tien-Hua Chen; Zen-Chung Weng; Pei-Jiun Tsai
Journal:  Stem Cells Int       Date:  2015-07-29       Impact factor: 5.443

5.  Islet product characteristics and factors related to successful human islet transplantation from the Collaborative Islet Transplant Registry (CITR) 1999-2010.

Authors:  A N Balamurugan; B Naziruddin; A Lockridge; M Tiwari; G Loganathan; M Takita; S Matsumoto; K Papas; M Trieger; H Rainis; T Kin; T W Kay; S Wease; S Messinger; C Ricordi; R Alejandro; J Markmann; J Kerr-Conti; M R Rickels; C Liu; X Zhang; P Witkowski; A Posselt; P Maffi; A Secchi; T Berney; P J O'Connell; B J Hering; F B Barton
Journal:  Am J Transplant       Date:  2014-10-02       Impact factor: 8.086

6.  Antidiabetic Effects of the Ethanolic Root Extract of Uvaria chamae P. Beauv (Annonaceae) in Alloxan-Induced Diabetic Rats: A Potential Alternative Treatment for Diabetes Mellitus.

Authors:  Jonathan Emeka Emordi; Esther Oluwatoyin Agbaje; Ibrahim Adekunle Oreagba; Osede Ignis Iribhogbe
Journal:  Adv Pharmacol Sci       Date:  2018-11-08

7.  The effect of a novel curcumin derivative on pancreatic islet regeneration in experimental type-1 diabetes in rats (long term study).

Authors:  Mohamed T Abdel Aziz; Mohamed F El-Asmar; Ameen M Rezq; Soheir M Mahfouz; Mohamed A Wassef; Hanan H Fouad; Hanan H Ahmed; Fatma M Taha
Journal:  Diabetol Metab Syndr       Date:  2013-11-26       Impact factor: 3.320

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.